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The removal of histone H3 lysine27 (H3K27) trimethy-
lation mark is important for the robust induction of
many cell type-specific genes during differentiation.
Here we show that UTX, a H3K27 demethylase,
acts as a critical switch to promote a cardiac-specific
gene program. UTX-deficient ESCs failed to develop
heart-like rhythmic contractions under a cardiac
differentiation condition. UTX-deficient mice show
severe defects in heart development and embryonic
lethality. We found that UTX is recruited to cardiac-
specific enhancers by associating with core cardiac
transcription factors and demethylates H3K27 resi-
dues in cardiac genes. In addition, UTX facilitates
the recruitment of Brg1 to the cardiac-specific
enhancers. Together, our data reveal key roles for
UTX in a timely transition from poised to active chro-
matin in cardiac genes during heart development and
a fundamental mechanism by which a H3K27 deme-
thylase triggers tissue-specific chromatin changes.
INTRODUCTION
In embryonic stem cells (ESCs), many developmental genes
exhibit ‘‘poised status’’ marked by bivalent trimethylation of
both histone H3-lysine 27 (H3K27me3) and H3-lysine 4
(H3K4me3) (Bernstein et al., 2006; Pan et al., 2007; Rada-Iglesias
et al., 2011; Zhao et al., 2007). Given that the H3K27me3 mark is
important to repressmany developmental genes in self-renewing
ESCs (Azuara et al., 2006; Bernstein et al., 2006; Boyer et al.,
2006; Lee et al., 2006b; Pan et al., 2007; Zhao et al., 2007), the
removal of H3K27me3 in a cohort of tissue-specific genes is likely
an important step in organogenesis. Despite recent progress in
understanding the changes of histone post-translational modifi-
cations during ESC differentiation, how histone modifying
enzymes make specific changes in a battery of lineage-specific
genes on the right time and space during development are
poorly understood. In particular, the identity of the histone
H3K27 demethylases that control cardiac gene expression and
the mechanisms by which they are recruited to cardiac-specificDeveenhancers remain unclear. Addressing these questions would
resolve a fundamental issue of how poised developmental genes
exit the transcriptionally purgatory state to achieve tissue-
specific gene expression during organogenesis.
Recent studies have identified UTX (also known as KDM6A),
UTY and JMJD3 (also known as KDM6B) as H3K27 demethy-
lases belonging to a family of JmjC-domain-containing proteins
(Agger et al., 2007; De Santa et al., 2007; Hong et al., 2007; Jep-
sen et al., 2007; Lan et al., 2007; Lee et al., 2007). UTX and
JMJD3 displayed specific catalytic activity in demethylating
H3K27me3/me2, whereas UTY was inactive under the same
assay conditions (Hong et al., 2007; Lan et al., 2007). Interest-
ingly, UTX and UTY constitute a large complex that contains
multiple subunits including H3K4 methyltransferase MLL3 or
MLL4 (Cho et al., 2007; Goo et al., 2003; Issaeva et al., 2007;
Lee et al., 2007, 2006a). It is unclear whether JMJD3 forms
a steady state complex like UTX. The UTX gene is encoded on
the X chromosome, but escapes X chromosome inactivation
(Greenfield et al., 1998). The UTY gene, the male counterpart
of UTX, is localized on the Y chromosome. Unlike UTX and
UTY, the JMJD3 gene is encoded in an autosome. Notably,
UTX is required for Hox gene activation and posterior develop-
ment in zebrafish embryos (Agger et al., 2007; Lan et al., 2007;
Lee et al., 2007), suggesting roles of UTX in development.
However, the function of H3K27 demethylases during cell fate
determination and organogenesis remains unknown.
To gain insight into the developmental roles of UTX, we
generated UTX-deficient ESCs and mice, and found that UTX
is essential for heart development. Our study also uncovered
the molecular basis underlying the action of UTX in inducing
cardiac genes during heart development. Overall, our results
provide important insights into how the histone modifying
enzymes orchestrate the establishment of transcriptionally
active chromatin in appropriate lineage-specific genes during
organogenesis.RESULTS
UTX Is Highly Expressed in the Developing Embryos
To understand the role of UTX in embryo development, we
generated mice bearing UTXF-loxP allele, in which b-galactosi-
dase gene was inserted into the UTX locus and exon 3 of UTX
was flanked by loxP sequences (Figure 1A). To examine thelopmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Inc. 25
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Figure 1. UTX Expression Pattern in the Developing Embryos
(A) Schematic representation of three mutant alleles of UTX.
(B–F) Whole-mount X-gal staining in E8.5 (B and C) and E11.5 (D–F)UTXF-loxP/+ embryos. X-gal stained areas inUTXF-loxP/+ embryos depict the embryonic tissues
expressing UTX. ant nt, anterior region of the neural tube; bc, bulbus cordis; br, brachial arches; ctx, cortex; f.l., forelimb; he, heart; h.l., hindlimb; is, isthmus; la,
left atrium; nt, neural tube; pv, primitive ventricle; ra, right atrium; sm, somites; sp, spinal cord; v, ventricle; vz, ventricular zone of the neural tube. See also
Figure S1.
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UTX in Heart Developmentexpression pattern of UTX in embryos, we performed X-gal stain-
ing in UTXF-loxP/+ embryos, in which b-galactosidase expression
is controlled by UTX regulatory elements, and found that UTX is
broadly expressed but is enriched in several tissues. At E8.5,
UTX was highly expressed in developing heart, anterior region
of the neural tube, ventricular zone of the caudal neural tube,
neural crest cells, and somites (Figures 1B and 1C). At E11.5,
UTX was enriched in heart, myotome of somites, limb buds,
brachial arches, isthmus, cortex, and eyes (Figure 1D). Cross-
sections of X-gal stained embryos revealed a high level of UTX
expression in cardiomyocytes (Figures 1C, 1E, and 1F). Consis-
tently, UTX transcripts are highly expressed in cardiomyocytes
of E10.5 hearts, as shown by in situ hybridization (Figure S1
available online). UTY is also expressed in E10.5 hearts (Fig-
ure S1). The expression pattern of UTX suggests possible roles
of UTX in organogenesis of several tissues including heart.
UTX Is Required for ESCs to Differentiate to a Cardiac
Lineage
To address the role of UTX during developmental transitions
from ESCs to a cardiac cell lineage, we used a well-established
protocol to differentiate ESCs to cardiac cell types, which closely
mimic in vivo development and provide cells at developmental
transitions (Boheler et al., 2002). We first generated UTXF-D/y26 Developmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier InESCs, in which exon 3 ofUTX is deleted, by inducing aCre-medi-
ated recombination in UTXF-loxP/y ESCs (Figure 1A). Neither UTX
mRNA nor UTX protein expression was detected in UTXF-D/y
ESCs (Figure 2A, data not shown), establishing that UTXF-D/y
ESCs are UTX null. UTXF-loxP/y ESCs showed reduced levels of
UTX mRNA and protein (Figure 2A, data not shown), indicating
that UTXF-loxP is a UTX hypomorphic allele.
UTX null ESCs were indistinguishable from wild-type ESCs in
cell proliferation and survival when cultured with leukemia inhib-
itory factor (LIF), as monitored by MTT assay and western blot-
ting assays with a-cleaved Caspase3 antibody (Figures 2B and
2C). Alkaline phosphatase staining revealed that, like wild-type
ESCs, UTX null ESCs self-renew in the presence of LIF, and
readily differentiate upon withdrawal of LIF and addition of reti-
noic acid (RA), which trigger ESC differentiation (Figure 2D).
Consistently, Oct4, a transcription factor essential for self-
renewal of ESCs, was downregulated and the expression of
markers for the three germ layers were induced in UTX null
ESCs under an ESC differentiation condition (Figures S2A–
S2D). These results indicate that UTX is not required for self-
renewal, proliferation, survival, and differentiation of ESCs.
Wild-type and UTX null ESCs were subjected to a well-estab-
lished protocol for differentiating ESCs into a cardiac lineage
(Figure S2E). The expression of UTX and UTY was nearlyc.
Figure 2. UTX Is Required for the Differenti-
ation of ESCs into a Cardiac Lineage
(A) RT-PCR using ESCs of various genotypes as
shown above. UTX expressionwas not detected in
UTX null (UTXF-D/y) ESCs. cycl. A, cyclophilin A.
(B) MTT assays to monitor proliferation of ESCs.
(C) Western blot to detect the levels of activated
Caspase3 in self-renewing ESCs (day 0) and
cardiac differentiated ESCs (day 10).
(D) Alkaline phosphatase staining of ESC colonies
under self-renewal condition (+LIF) and differenti-
ation condition incubated with RA in the absence
of LIF (+RA/LIF). UTX null ESCs self-renew and
readily differentiate when stimulated with RA, like
wild-type ESCs.
(E, F, and I–L) Quantitative RT-PCR to monitor
mRNA levels during cardiac differentiation of wild-
type ESCs (UTX+/y, black dotted lines) and UTX
null ESCs (UTXF-D/y, gray lines). x axis, differenti-
ation days; y axis, relative mRNA levels. UTX null
ESCs did not induce cardiac-specific genes
during cardiac differentiation. The mRNA level in
wild-type ESCs at day 0 was calculated as 1.
(G) Quantification of cEBs that show heart-like
spontaneous contraction among all EBs. UTX null
ESCs failed to form beating cEBs.
(H) TUNEL assays in cardiac differentiated EBs
(cEBs, day 10). UTX null cEBs do not show more
cell death than wild-type cEBs. Error bars repre-
sent the standard deviation in all graphs (B, E–G,
and I–L). See also Figure S2.
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UTX in Heart Developmentdoubled during cardiac differentiation in ESCs (Figures 2E and
2F). Notably, the expression of UTY as well as UTX was abol-
ished in UTX null ESCs (Figures 2E and 2F), suggesting that
UTY expression in male ESCs is dependent on UTX. We then
monitored the differentiation of ESCs into cardiac lineage-
committed embryoid bodies (cEBs) that show heart beating-
like rhythmic contractions, a unique functional property of
pulsating cardiac muscle cells. Almost 100% of EBs from wild-
type ESCs exhibited prominent beating (Figure 2G). In the
parallel condition, however, EBs derived from UTX null ESCs
failed to develop spontaneous contraction (Figure 2G). Only
26% of UTXF-LoxP/y EBs displayed spontaneous beating (Fig-
ure 2G). UTX null EBs did not undergo more cell death thanDevelopmental Cell 22, 25–3wild-type EBs during cardiac differentia-
tion, as shown by detection of activated
Caspase3 and TUNEL staining (Figures
2C and 2H), indicating that a failed forma-
tion of contracting EBs from UTX null
ESCs was not due to excessive cell
death. Next, we examined the induction
of cardiac-specific genes during cardio-
myocyte differentiation in wild-type and
UTX null ESCs. Atrial natriuretic factor
(ANF), the ventricular isoform of the
myosin regulatory light chain (MLC2v),
a-cardiac actin (a-CA), cardiac muscle
myosin heavy chain 6 (Myh6), and
cardiac-specific troponin T2 were mark-
edly induced in wild-type ESCs duringdifferentiation (Figures 2I–2L, data not shown). However, under
the same conditions, these cardiac-specific genes were not up-
regulated in UTX null ESCs, consistent with the morphological
defects in developing contraction (Figures 2G and 2I–2L, data
not shown). Together, these data establish that UTX is required
for cardiac lineage differentiation of ESCs and robust induction
of the cardiac genes during cardiac differentiation.
UTX Null Mice Are Defective in Cardiac Development
To address the role of UTX in vivo, we created mice with UTXD
allele by crossing the UTXF-loxP/+ mice with Rosa-Flp and EIIa-
Cremice, which constitutively express Flp and Cre recombinase
respectively, in succession (Figure 1A) (Farley et al., 2000; Lakso7, January 17, 2012 ª2012 Elsevier Inc. 27
Figure 3. UTX Is Required for Early Heart Development
(A–F) Images of E9 littermate wild-type embryo (UTX+/y, A, A0, B, and E) and UTX null embryo (UTXD/D, C, C0, D, and F), and H&E staining of E9 embryonic hearts
(E and F). At E9,UTX null embryonic hearts displayed no overt looping, whereas wild-type embryos underwent cardiac looping morphogenesis, adopting a spiral
shape consisting of cardiac chambers. UTX null embryos also show neural tube closure defects (red arrow in C).
(G and H) Immunohistochemical analyses with a proliferation marker Ki67, TUNEL labeling, and myocardiac lineage markers Nkx2.5 and Isl1. ht, heart tube.
(I–Z) Whole-mount in situ hybridization analyses of E9 embryos with probes of various cardiac genes, including Nkx2.5 (I–L), Tbx5 (M–P), ANF (Q–T), and MLC2v
(U–Z). Lateral view from left side of the embryos or ventral view are shown as indicated. Transverse sections of MLC2v-hybridized embryos corresponding to the
dotted lines in (W) and (X) are shown in (Y) and (Z), respectively. In E9UTX null embryos, expression of ANF andMLC2vwasmarkedly downregulated compared to
control embryos, and the separate chamber formation did not occur. lv, left ventricle; nt, neural tube; rv, right ventricle; v, ventricle. (A–D and I–Z) Relative position
of embryos was marked by V (ventral), D (dorsal), right (R), and left (L) along with arrows. See also Figure S3 and Figure S4.
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UTX in Heart Developmentet al., 1996). UTXD/D female and UTXD/y male mice did not
express detectable levels of UTX transcripts (Figure S3A). UTY
is expressed in both wild-type UTX+/y and UTX null UTXD/y
male embryos at E8.5 (Figure S3B), suggesting that UTY expres-
sion in developing male embryos is independent on UTX, unlike
male ESCs. UTY expression was not detected in female
embryos, as expected (Figure S3B). UTXD/D female mice, which
do not have the UTY gene, did not survive past E10.5, whereas
UTXD/+ heterozygote female mice were viable and fertile.
UTXD/y male mice displayed embryonic lethality and severe
developmental retardation, but some UTXD/y mice that escaped
embryonic lethality lived into adulthood. Thus, UTX is required
for the survival of female embryos, and UTY partially compen-
sates for the loss of UTX in males.
UTXD/D female embryos exhibited severe cardiac malforma-
tion and neural tube closure defects, while their allantois ap-28 Developmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Inpeared to develop normally (Figures 3A–3F, data not shown).
At E9, UTXD/+ and UTX+/y sibling embryos displayed cardiac
looping morphogenesis, which marks chamber formation and
results in a physical separation between the primitive atrial and
ventricular regions, and completed neural tube closure in the
anterior region (Figures 3A and 3B). In contrast, UTXD/D embry-
onic hearts largely retained a tubular heart structure and their
neural tubes remained open in the anterior portion (Figures 3C
and 3D; Figure S3C). We further examined the gross structure
of hearts by performing hematoxylin and eosin staining on the
transverse sections of E9 embryos. As predicted, hearts of
UTXD/+ and UTX+/y embryos were highly looped and consisted
of separate chambers, whereas UTXD/D embryos were largely
linear throughout the heart tube and lacked chamber develop-
ment (Figures 3E and 3F). In addition, the myocardium of UTX
null embryos appeared thinner than that of littermate controlc.
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UTX in Heart Developmentembryos (Figures 3E and 3F). At E10.5, UTXD/D embryos were
markedly growth retarded as compared to wild-type littermates,
and were completely reabsorbed by E11.5 (data not shown).
These results indicate that UTX is needed for early heart devel-
opment and neural tube closure.
Impaired Cardiac Differentiation in UTX Null Embryos
To understand the basis for the cardiac defects in E9 UTX null
embryos, we analyzed cell proliferation and survival in E8.5
embryos using Ki67 and TUNEL staining and found little differ-
ence between UTX null and UTXD/+ heterozygote embryonic
hearts (Figure 3G). Next, we monitored expression levels of
core cardiac transcription factors using quantitative RT-PCR
with E8.5 littermate whole embryos. The expression of the four
core cardiac factors, Nkx2.5, Tbx5, GATA4, and SRF, was com-
parable among embryos of various genotypes at E8.5 (Figures
S3D–S3F). Immunohistochemical analyses revealed that both
Nkx2.5+Isl1 and Nkx2.5+Isl1+ myocardial lineage cells are
specified in E8.5UTX null embryos (Figure 3H). UTX is expressed
in both myocardial lineages (Figure S4). Together, these results
suggest that proliferation, survival, and initial fate specification
are not overtly disturbed in myocardial lineage cells of UTX null
embryos at E8.5.
Next, we examined expression of Nkx2.5 and Tbx5 in E9 UTX
null and control littermate embryos using whole-mount in situ
hybridization analyses. Nkx2.5 and Tbx5 were highly expressed
in the sinoatrial structures and heart tube ofUTXD/D embryos, but
the overall levels were reduced compared to those in UTXD/+
littermates (Figures 3I–3P), suggesting that UTX plays a role in
maintaining high levels of Nkx2.5 and Tbx5 in the developing
heart. To monitor the expression of heart-specific genes that
are regulated by the core cardiac transcription factors, we per-
formed whole mount in situ hybridization analyses in littermate
embryos. ANF, an atrial natriuretic peptide, is a marker of the
differentiating chamber myocardium. SRF, Tbx5, Nkx2.5, and
GATA4, alone or in combination, bind to their cognate sites in
the ANF enhancer and activate its transcription (Bruneau et al.,
2001; Charron and Nemer, 1999; Durocher and Nemer, 1998;
Garg et al., 2003; Hiroi et al., 2001; McBride and Nemer, 2001;
Small and Krieg, 2003, 2004; Tanaka et al., 1999; Thuerauf
et al., 1994). In addition, Nkx2.5 and Tbx5 also activate expres-
sion of the ventricle-specific contractile protein MLC2v (Bruneau
et al., 2001; Lyons et al., 1995; Tanaka et al., 1999).Whole-mount
in situ hybridization revealed that ANF expression was greatly
reduced in UTXD/D embryonic heart (Figures 3Q–3T). In addition,
MLC2v was also substantially decreased and the expression
pattern of MLC2v was severely altered in UTXD/D embryos
(Figures 3U–3Z). Together, our data establish that UTX plays
a crucial role in maintaining high levels of Nxk2.5 and Tbx5
expression and marked upregulation of heart-specific genes
during embryonic development.
UTX Functions as a Coactivator of the Core Cardiac
Transcription Factors
Given thatUTX null mice exhibit severely arrested heart develop-
ment and downregulation of ANF and MLC2v, target genes of
core cardiac transcription factors, we asked whether UTX func-
tions as a coactivator of any of the cardiac transcription factors.
To test this idea, we first examined the association between UTXDeveand serum response factor (SRF), a MADS box factor that
functions as a strong activator to induce cardiac-specific gene
transcription during development (Miano et al., 2004; Niu et al.,
2005; Parlakian et al., 2004; Shore and Sharrocks, 1995). We
performed coimmunoprecipitation (CoIP) assays in HEK293T
cells transfected with Myc-tagged UTX and HA-tagged SRF,
and found that UTX associates with SRF in cells (Figure 4A).
Furthermore, we detected the interaction between endogenous
UTX and SRF by CoIP assays in the developing heart tissues
(Figure 4B; Figure S5A). Neither UTX nor SRF associated with
Ezh2, a histone H3K27 methyltransferase, in the hearts (Fig-
ure S5A), confirming the specificity of interaction between UTX
and SRF (Figure S5A).
To test whether UTX affects the transcriptional activity of SRF,
we performed cell-based reporter assays using luciferase
reporters linked to synthetic serum response elements (SREs)
or enhancer elements of ANF, SM22, or a-CA gene, each of
which contains essential SRF binding sites (Chen and Schwartz,
1996; Li et al., 1997; Small and Krieg, 2004; Strobeck et al.,
2001). UTX enhanced SRF-mediated transcriptional activation
in all SRF-responsive reporters in a dose-dependent manner,
while UTX alone had little effect without SRF (Figures 4C and
4D; Figures S5B and S5D). Conversely, shRNA-mediated knock-
ing down of endogenous UTX strongly suppressed the SRF-
mediated activation, which was rescued by expression of
shRNA-insensitive form of UTX (Figures 4E and 4F; Figures
S5C and S5E). These data demonstrate that UTX is important
for the SRF-mediated transcriptional activation.
Next, we tested whether UTX cooperates with other core
cardiac transcription factors. CoIP assays demonstrated that
UTX associates with Tbx5, Nkx2.5, and GATA4 in HEK293T cells
(Figures 4G–4I). Likewise, CoIP assays in E12.5 hearts revealed
the interaction of UTX with endogenous Tbx5, Nkx2.5, and
GATA4 (Figure 4J). In contrast, UTX did not interact with Pax6
homeodomain transcription factor in HEK293T cells (Figure S5F),
confirming the specificity of association between UTX and core
cardiac transcription factors.
The proximal enhancer of ANF bears the critical response
elements for Tbx5, Nkx2.5, and GATA4 in addition to SRF (Bru-
neau, 2002; Bruneau et al., 2001; Charron and Nemer, 1999;
Durocher and Nemer, 1998; Garg et al., 2003; Hiroi et al.,
2001; McBride and Nemer, 2001; Small and Krieg, 2003, 2004;
Tanaka et al., 1999; Thuerauf et al., 1994). Consistent with the
observed interactions between UTX and the cardiac transcrip-
tion factors, UTX expression further potentiated Tbx5, Nkx2.5
and GATA4-dependent activation of the ANF enhancer, while
UTX-shRNA inhibited this activation (Figures 4K and 4L; Figures
S5G–S5J). Interestingly, we found that Tbx5 and SRF synergize
in activating the ANF enhancer (Figures 4M and 4N). UTX
strengthened this combinatorial action of Tbx5 and SRF, and
UTX-shRNA suppressed this action (Figures 4M and 4N). Simi-
larly, UTX also supported the cooperative actions of Nkx2.5
and GATA4 in activating the ANF enhancer, and UTX-shRNA
inhibited this action (Figures S5K and S5L). Combined with the
phenotypic analyses of UTX null hearts, our results suggest
that UTX potentiates the induction of heart-specific genes, at
least in part, by functioning as an essential common coactivator
for the core cardiac transcription factors, SRF, Tbx5, Nkx2.5,
and GATA4.lopmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Inc. 29
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Figure 4. UTX Functions as a Coactivator of the Cardiac Transcription Factors SRF, Nkx2.5, Tbx5, and GATA4
(A and G–I) CoIP assays in HEK293T cells transfected with Myc-UTX and the cardiac transcription factors. UTX associates with SRF, Nkx2.5, Tbx5, and GATA4
in cells.
(B and J) CoIP assays using a-UTX antibody for western blotting assays in dissected E12.5 embryonic hearts. The antibodies used for immunopurification were
marked on the top.
(C–F and K–N) Luciferase reporter assays using SRE:luciferase (C and E) and ANF:luciferase (D, F, and K–N) reporters with vectors indicated below each graph.
The transcriptional activity of SRF, Tbx5, and Nkx2.5, alone or in combination, was enhanced by UTX, and inhibited by UTX-shRNA (sh-UTX). The basal luciferase
activity for each reporter was calculated as 1 in y axis. + and ++ represent relative dosage of plasmids used for transfection. Error bars represent the standard
deviation in all graphs. *p < 0.05; **p < 0.01 in two-tailed Student’s t test. See also Figure S5.
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UTX in Heart DevelopmentUTX Is Recruited to Cardiac-Specific Enhancers
Our results predict that UTX is recruited to cardiac-specific
enhancers to control cardiac gene expression in the developing
heart. To test this prediction, wemonitored the binding of endog-
enous UTX to cardiac enhancers using chromatin immunopre-
cipitation (ChIP) assays with an a-UTX antibody in dissected
hearts, limbs and brains from E12.5 mouse embryos. UTX was
strongly recruited to the ANF enhancer that contains the key
responsive elements for SRF, Tbx5, Nkx2.5, and GATA4 in
embryonic hears, whereas its binding to the ANF enhancer in
embryonic limbs and brains was much weaker (Figures 5A and
5B). Similarly, UTX bound to the cardiac-specific enhancer of
a Brg1-associated factor Baf60c, which was co-occupied by
SRF, Nkx2.5, and GATA4 (He et al., 2011), in hearts, but UTX
did not bind to theBaf60c enhancer efficiently in limbs and brains30 Developmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier In(Figure 5C). These data underline a heart-specific recruitment of
endogenous UTX to the cardiac enhancers, which are coregu-
lated by core cardiac transcription factors, in embryos.
To test whether UTX binding to the cardiac enhancers is
developmentally regulated, we performed ChIP assays in self-
renewing pluripotent ESCs and differentiated cEBs that display
spontaneous heart-like beating. As expected, the expression
of Tbx5, Nkx2.5, SRF, and GATA4 was induced as ESCs differ-
entiate to cEBs (Figures S6A–S6D). Interestingly, UTX was re-
cruited to the ANF enhancer in cEBs that express cardiac
transcription factors, while it did not bind to the enhancer in
self-renewing ESCs (Figure 5D). Likewise, ESC differentiation
into cEBs induced UTX to bind to the Baf60c enhancer (Fig-
ure 5E). These data suggest that the recruitment of UTX to the
cardiac-specific genes is facilitated during the developmentalc.
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Figure 5. UTX Is Recruited to the Cardiac Genes in a Cardiac Cell-Type Specific Manner and Triggers the Demethylation of H3K27 Resides
(A) Schematic representation of the ANF gene. The arrows indicate two sets of primers detecting ANF-enhancer (ANF-enh) and ANF-exon1 (ANF-ex1). The
specific response elements for the cardiac transcription factors are also indicated.
(B–E) ChIP assays with a-UTX antibody in dissected tissues from E12.5 embryos (B and C) or ESCs (D and E). (D and E) Wild-type ESCs (UTX+/y, black bars) and
UTX null ESCs (UTXF-D/y, gray bars) were cultured under self-renewing ESC condition (E) or cardiac differentiation condition (C). UTX is efficiently recruited to the
ANF-enhancer and Baf60c-enhancer only in hearts or cEBs, but UTX binding to the cardiac enhancers is very weak in limbs, brains, and self-renewing ESCs.
(F and G) ChIP assays with a-H3K27me3 in P19 cells treatedwith serum shock and transfected with sh-UTX and UTX expression vectors as indicated below each
graph. UTX-wt, wild-type UTX; UTX-mt, catalytically inactive UTX. (B–G) The quantitative PCR levels in IgG sampleswere calculated as 1. Error bars represent the
standard deviation in all graphs. See also Figure S6.
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UTX in Heart Developmenttransition of ESCs into the cardiac lineage, likely due to upregu-
lation of the cardiac transcription factors and UTX and their
subsequent association. Together, these data show that the
occupancy of UTX to the cardiac lineage genes is controlled in
a developmental stage- and tissue-specific manner.
UTX Mediates Demethylation of H3K27 Residues
in Cardiac-Specific Genes
The recruitment of UTX to the cardiac genes led us to ask
whether UTX functions as a H3K27 demethylase enzyme that re-
moves a repressive transcription mark H3K27me3 in cardiac
genes upon the activation and/or expression of the cardiac tran-
scription factors. To this end, we monitored the H3K27me3
levels in the cardiac enhancers with or without serum shock,
which promotes the transcriptional activity of SRF, in P19mouse
embryonic cells. The H3K27me3 levels in the ANF and Baf60c
enhancers were markedly suppressed when SRF was activated
by serum shock (Figures 5F and 5G). This SRF-mediated deme-
thylation of H3K27 in the cardiac enhancers was blocked by
shRNA-mediated knockdown of endogenous UTX (Figures 5F
and 5G), suggesting that UTX is a demethylase that eliminates
the H3K27me3mark. Further supporting this idea, re-expression
of UTX wild-type repressed the elevated H3K27me3 levels in the
cardiac enhancers inUTXknockdownconditions,while a catalyt-
ically inactive UTX mutant failed to rescue the UTX knockdownDevephenotype (Figures 5F and 5G). The expression levels of UTX
wild-type and mutant were comparable (data not shown). These
data demonstrate that UTX enzymatic activity is needed for the
activated SRF to remove a repressive mark H3K27me3 in the
cardiac genes.
UTX Facilitates the Recruitment of Brg1 to
Cardiac-Specific Genes
The ATP-dependent chromatin remodeling Swi/Snf complex
containing Brg1, an ATPase subunit, plays crucial roles in heart
development and potentiates the transcription activity of core
cardiac transcription factors (Hang et al., 2010; Lickert et al.,
2004). Interestingly, it was reported that H3K27 demethylases
mediate a functional interaction between a T-box transcription
factor T-bet and the Brg1-complex (Miller et al., 2010). Our find-
ings that UTX functions as a coactivator of cardiac transcription
factors, alongwith the known roles of Brg1 in heart development,
raise the question of whether UTX also contributes to heart-
specific gene expression by recruiting the Brg1-containing Swi/
Snf chromatin remodeling complex to the cardiac genes. We
found thatUTXassociateswithBrg1 inHEK293Tcells (Figure6A).
We then tested whether UTX facilitates the interaction between
Tbx5 and Brg1 using CoIP assays in HEK293 cells transfected
HA-tagged Tbx5 with or without UTX. Expression of UTX greatly
promoted the interaction between Tbx5 and Brg1 (Figure 6B).lopmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Inc. 31
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Figure 6. The Demethylase Activity-Independent Function of UTX in
Brg1 Recruitment to the Cardiac Genes
(A) CoIP assays in HEK293T cells. UTX associates with Brg1.
(B) CoIP assays in HEK293T cells transfectedwith HA-Tbx5. UTXmediates the
interaction between Tbx5 and Brg1.
(C and D) ChIP assays with a-Brg1 in P19 cells treated with serum shock and
transfected with sh-UTX and UTX expression vectors as indicated below each
graph. UTX-wt, wild-type UTX; UTX-mt, catalytically inactive UTX. The quan-
titative PCR levels in IgG samples were calculated as 1. Error bars represent
the standard deviation in all graphs.
A
B
C
Figure 7. Role of UTX in Establishing Active Chromatin in Cardiac-
Specific Genes and Model for Action of the UTX-Complex During
Developmental Transition of ESCs to Cardiac Cells
(A and B) ChIP assays with a-H3K27me3 (A) and a-H3K4me3 (B) antibodies in
self-renewing ESCs (E) and cEBs (C) using wild-type ESCs (UTX+/y, black bars)
and UTX null ESCs (UTXF-D/y, gray bars). The ANF gene loses a repressive
mark H3K27me3 and gains an activating mark H3K4me3 during cardiac
differentiation in wild-type ESCs, but these chromatin changes do not occur in
UTX null ESCs. The quantitative PCR levels in IgG samples were calculated as
1. Error bars represent the standard deviation.
(C) UTX acts as a critical switch to drive cardiac lineage in development. X
represents the cardiac transcription factors SRF, Tbx5, Nkx2.5, and GATA4,
and XRE depicts the response elements of these cardiac transcription factors
that control expression of a battery of cardiac-specific genes. During cardiac
differentiation, the cardiac transcription factors are induced in expression,
bind to the XREs of cardiac genes, and recruit the UTX-complex, which re-
moves the H3K27me3 repressive mark. In addition, UTX promotes the
recruitment of the Brg1-complex to the cardiac genes in a demethylase
activity-independent manner. UTX may also facilitate the recruitment of
histone H3K4 methyltransferases MLL3 and MLL4 that form a complex with
UTX. These establish active chromatin in the cardiac genes and triggering the
transcription.
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heart-specific genes, we monitored the recruitment of Brg1 to
the ANF and Baf60c enhancers in P19 cells treated with serum
shock. Brg1 binding to the cardiac enhancers was substantially
reduced by UTX knockdown (Figures 6C and 6D), suggesting
that endogenous UTX facilitates the recruitment of Brg1 to the
cardiac enhancers. Interestingly, enzymatically inactive UTX,
as well as wild-type UTX, enhanced Brg1-binding to the cardiac
enhancers (Figures 6C and 6D). These data suggest a demethy-
lase activity-independent function of UTX in facilitating the
recruitment of the Brg1-containing chromatin remodeling com-
plex to the cardiac-specific genes.
UTX Is Required to Trigger Transcriptionally Active
Chromatin in Cardiac-Specific Genes
Considering the recruitment of UTX to the cardiac enhancers
during cardiac lineage differentiation, we asked whether UTX is
important to shift the chromatin signature of the cardiac-specific
genes from a poised state in self-renewing ESCs to an active
state in cEBs. The H3K27me3 levels in the ANF enhancer were
high in ESCs, and substantially reduced as wild-type ESCs
differentiated into cEBs (Figure 7A), as levels of ANF transcript
increased (Figure 2I). In sharp contrast, in UTX null ESCs, the
ANF-H3K27me3 levels were not suppressed under a cardiac32 Developmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Indifferentiation condition (Figure 7A), suggesting that UTX is
required to remove the H3K27me3 repressive mark in the ANF
enhancer during cardiac development. These changes in the
H3K27me3 levels were not specific to the ANF gene. UTX null
ESCs also failed to suppress the H3K27me3 levels efficiently
during cardiac differentiation in the Baf60c enhancer and the
enhancer of a-CA, which contains the binding sites for SRF,
Nkx2.5, and GATA4 (Chen and Schwartz, 1996; Sepulveda
et al., 1998), while their H3K27me3 levels declined in wild-type
cEBs (data not shown). These results suggest that UTX is impor-
tant to eliminate the H3K27me3 mark in cardiac genes during
cardiac lineage specification.
Interestingly, the H3K4me3 levels in the ANF gene remained
unchanged and relatively low during cardiac differentiation in
UTX null ESCs, while the ANF-H3K4me3 levels were highly
induced under parallel differentiation conditions in wild-type
ESCs (Figure 7B). We also obtained the similar data with the
Baf60c enhancer (data not shown). These data indicate that inc.
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removal of H3K27me3 and deposition of H3K4me3, thus main-
taining the repressive chromatin in cardiac genes (Figure 7C).
This failure of establishment of active chromatin in cardiac genes
likely contributes to various defects in UTX null embryonic
hearts.
DISCUSSION
Cardiac lineage decisions and the subsequent morphogenesis
of the early developing heart are orchestrated by a set of tran-
scription factors, including SRF, Tbx5, Nkx2.5, and GATA4,
which support each other’s expression and act in combination
to control the overlapping target genes (Bruneau, 2002; Garg
et al., 2003; Hiroi et al., 2001; McBride and Nemer, 2001; Olson,
2006; Searcy et al., 1998; Sepulveda et al., 1998; Small and
Krieg, 2004; Tanaka et al., 1999). In spite of crucial roles of
histone methylation in gene regulation and development (Bhau-
mik et al., 2007; Cloos et al., 2008), the identity of enzymes that
control histone methylation levels for cardiac lineage-specific
genes was unclear. We found that UTX is recruited to the cardiac
genes by associating with core cardiac transcription factors
Nkx2.5, Tbx5, GATA4, and SRF, thereby activating heart-
specific genes in cardiac lineage cells, but not in other cell types
that do not express the cardiac transcription factors (Figure 7C).
Considering broad expression of UTX in multiple tissues, the
association of UTX with the cardiac transcription factors likely
plays an important role for specifically targeting UTX to cardiac
genes only in cells committed to a cardiac lineage. The adjacent
locations of SRF, Tbx5, Nkx2.5, and GATA4 binding sites in the
enhancer regions of many developmentally regulated cardiac
genes (Bruneau, 2002; He et al., 2011; McBride and Nemer,
2001; Small and Krieg, 2004) are likely crucial to recruit UTX
more efficiently to cardiac genes, as UTX associates with
multiple transcription factors that co-occupy the enhancers.
Our data support two mechanisms by which UTX activates
transcription of cardiac genes after UTX is recruited to the genes
via association with cardiac transcription factors. First, UTX,
a histone H3K27 demethylase, eliminates the H3K27me3 repres-
sivemark in heart-specific genes during cardiac differentiation to
allow transcriptional activation. UTX knockdown blocks the acti-
vated SRF from reducing the H3K27me3 levels in the cardiac
genes, which was rescued by UTXwild-type but not by enzymat-
ically inactive UTX. Consistently, in the absence of UTX, cardiac
genes are still marked by the H3K27me3 even under a cardiac
differentiation condition. These data suggest that the enzymatic
activity of UTX is crucial in establishing a transcriptionally active
chromatin in cardiac genes. Second, UTX associates with Brg1
and facilitates the recruitment of the Brg1-containing ATPase-
dependent Swi/Snf chromatin-remodeling complex to the
cardiac genes. Interestingly, this function of UTX appears inde-
pendent of its demethylase activity. Consistently, a catalytically
inactive UTX mutant enhanced the activity of the cardiac tran-
scription factors in luciferase assays and partially restored the
transcription of some UTX target genes inhibited by UTX knock-
down (data not shown). Our data indicate that UTX strongly
promotes the association between Brg1 and Tbx5. JMJD3,
another histone H3K27 demethylase, has also been shown to
mediate the association between Brg1 and a T-box factorDeveT-bet in T helper cells (Miller et al., 2010). Thus, H3K27 demethy-
lases may act to bridge the Brg1-containing Swi/Snf complex
and developmental transcription factors in multiple cell types.
It is worth noting that Baf60c, a heart-specific component
of the Brg1-complex, mediates the association between Brg1
and multiple cardiac transcription factors, such as Tbx5,
Nkx2.5, and GATA4, and potentiates cardiac gene expression
(Lickert et al., 2004). In the future, it will be interesting to investi-
gate the relationship between UTX and Baf60c in the Brg1-
dependent transcriptional activation of cardiac genes.
Our studies revealed that loss of UTX disrupts the coordination
of H3K4 and H3K27 methylations on poised cardiac genes
during cardiac differentiation. These observations suggest that
H3K27 demethylation is intricately linked to H3K4 methylation
and that UTX is essential in orchestrating the chromatin signa-
ture of the cardiac genes from a poised to active state in the
developing heart. UTXmay be important to bring the H3K4meth-
yltransferases MLL3/4 to the cardiac genes during development
(Figure 7C), given they form a steady-state complex with MLL3
or MLL4 (Cho et al., 2007; Goo et al., 2003; Issaeva et al.,
2007; Lee et al., 2007, 2006a). Investigating a role of UTX in re-
cruiting MLL3/4 methyltransferases to cardiac genes will help
understand how histone codes are tightly coordinated in cell
lineage-specific genes during organogenesis.
Altogether, our findings establish UTX as a central player in
heart development and point to an intriguing possibility that
cardiac-specific gene and signaling networks converge on
UTX to trigger a wide range of cardiac gene transcription during
development. Our findings may contribute to development of
novel strategies to efficiently produce cardiomyocytes from
stem cells for therapeutic purpose.
The removal of the transcriptionally repressive chromatinmark
H3K27me3 is likely important for the gene expression for
multiple lineages. Relatively broad expression of UTX suggests
its possible role beyond cardiac development. Indeed, UTX
null embryos exhibit neural tube closure impairment as well as
cardiac defects, consistent with an exencephaly phenotype of
mutant mice with a UTX gene trap allele (Cox et al., 2010). Inter-
estingly, our data show that UTX null ESCs are not defective
in cellular differentiation in general. Under a differentiation
condition with RA, UTX null ESCs stop self-renewal and readily
differentiate. In addition, UTX null embryos develop until E9.5.
We also found that UTX null ESCs differentiate into neurons,
similarly to wild-type ESCs (data not shown). It is possible that
UTX is dispensable for differentiation of certain cell lineages
and/or that JMJD3, another H3K27 demethylase, functions
redundantly with UTX. Analyses of JMJD3-deficient mice and
mutant mice lacking both JMJD3 and UTX may be employed
to address specific and redundant functions of JMJD3 and
UTX in future.
A single allele mutation in UTX gene in males is sufficient to
inactivateUTX gene as it is located on the X chromosome. In light
of this, it is noteworthy that somaticmutations of UTXwere found
in various human cancers (van Haaften et al., 2009).UTXD/ymale
mice displayed a wide range of phenotypes from embryonic
lethality with severe cardiac malformation to tumor formation in
adults, while UTXD/+ heterozygote female mice were viable and
fertile. UTXD/D female mice invariably show embryonic lethality.
These analyses of UTX-deficient mice suggest that UTYlopmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier Inc. 33
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previous studies that UTY lacks the H3K27 demethylase enzy-
matic activity in vitro (Hong et al., 2007; Lan et al., 2007),
compensation of UTX deficiency by UTY might be attributed to
its demethylase activity-independent functions such as recruit-
ment of Brg1 to the developmental transcription factors.
However, it is still possible that UTY exhibits demethylase
activity under certain in vivo contexts. Further investigation into
the redundant and unique actions of UTX and UTY will provide
important insights into not only the developmental roles of
histone demethylases but also their anti-tumorigenic functions.
Our UTX-deficient mice will serve as crucial tools for future
investigation.
EXPERIMENTAL PROCEDURES
Generation of UTX Null ESCs
UTXF-loxP ESCs were obtained from the European Conditional Mouse
Mutagenesis Program (EUCOMM). UTXF-loxP ESCs and their wild-type coun-
terparts were maintained on top of irradiated mouse embryonic fibroblast
(MEF) feeder cells in propagation medium consisting of Knockout-DMEM
(Dulbecco’s modified Eagle’s medium), 10% fetal bovine serum, 2 mM
L-glutamine, 0.1 mM nonessential amino acids, 0.1 mM b-mercaptoethanol,
and leukemia inhibitory factor (LIF; 1,000 units/ml, Chemicon). To generate
UTXF-D/y ESCs that are deficient in exon 3 of the UTX gene, 2000 UTXF-loxP
ESCs were plated in 35 mm dish with MEF feeder cells for 24 hr and trans-
fected with pOG231-Cre plasmid (Addgene) using Lipofectamine 2000
(Invitrogen). Three days later, single colonies were picked, further amplified,
and verified for the loss of UTX expression by western blot and RT-PCR
analyses. PCR was used to determine the genotype of ESCs with the primers
50-GTTGTGGTTTGTCCAAACTCA-30 and 50-CGAGTGATTGGTCTAATTT
GG-30. The amplified product from the UTXF-D allele is 209 bp, whereas that
from the UTXF-loxP allele is 996 bp. Additional set of primers was also used
to determine the UTXF-loxP allele, which produces 264 bp PCR product;
50-GTTGTGGTTTGTCCAAACTCA-30 and 50-CTGTAATCTCTGCTGATACAA-30.
Generation of UTX-Deficient Mice
UTXF-loxP ESCs were introduced into mouse blastocysts. Chimeric mice were
mated with wild-type C57BL6 mice. UTXF-loxP/+ heterozygous F1 mice were
mated to Rosa-Flp mice to delete the sequences between FRT sites (Farley
et al., 2000). To delete exon 3 of UTX constitutively, EIIa-Cre mice (Lakso
et al., 1996) were crossed with mice bearing UTX-floxed allele. Genotyping
was performed by PCR using primers 50-TCTGGTATAGATTTTGGCTAA-30
and 50-CGAGTGATTGGTCTAATTTGG-30. PCR reaction results in 932 bp
product from wild-type allele and 286 bp product from UTX null allele. All
animal procedures were conducted in accordance with the Guidelines for
the Care andUse of Laboratory Animals andwere approved by the Institutional
Animal Care and Use Committee at Oregon Health and Science University.
Differentiation ESCs into a Cardiac Lineage
Cardiac differentiation of ESCs was performed as previously described (Boh-
eler et al., 2002). Briefly, 500 ESCs in 20 ml of differentiation medium (ESC
growth medium without LIF) were placed on the lids of 150 mm Petri dishes
for 2 days. The aggregated ESCs, now termed embryoid bodies (EBs), were
floated in bacteriological low attach dishes for 5 days and medium was
changed every other day. At day 7, EBs were plated onto tissue culture dishes
coated with 0.1% gelatin. Spontaneous beating areas could be detected as
early as day 8 (day 0 means the day when hanging drops were seeded).
AP Staining
To measure AP activity, 3,000 cells/well were seeded on MEF feeder cells in
24-well plate in propagation medium. For ESC differentiation, 1 mM of retinoic
acid (RA) was added in the absence of LIF. At day 4, cells were fixed in 4%
paraformaldehyde/PBS and AP activity was measured using alkaline phos-
phatase detection kit (Chemicon #SCR004).34 Developmental Cell 22, 25–37, January 17, 2012 ª2012 Elsevier InMTT Cell Proliferation Assays
A total of 500 cells/well were seeded on MEF feeder cells in 96-well plate in
propagation medium. Ten microliters of MTT (3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide, 5 mg/ml, Sigma) solution was added to each
well containing cells and incubated at 37C. Six hours later, medium was
removed and 200 ml of dimethyl sulfoxide (DMSO) was added and absorbance
was measured at 550 nm using spectrophotometer.
TUNEL Assays
To monitor cell death, differentiated cEBs and E8.5 embryos were analyzed
with In situ cell death detection kit, TMR red (Roche). Briefly, tissues were fixed
in 4% paraformaldehyde for 20 min at room temperature, washed with PBS
twice, permeabilized (0.1% Triton X-100 in 0.1% sodium citrate), washed
with PBS twice and TUNEL reaction mixture was added and incubated for
1 hr at 37C.
Immunohistochemistry and In Situ Hybridization Assays
For immunohistochemistry and in situ hybridization analyses, the embryos
were harvested at indicated stage, fixed in 4% paraformaldehyde, embedded
in OCT, and cryosectioned at 12–18 mm. Immunohistochemistry was per-
formed as described (Lee et al., 2009) using the following antibodies and
reagents: a-Ki67 (Novocastra), a-Nkx2.5 (H-114, Santa Cruz), a-Isl1 (DSHB),
and a-UTX (a gift from K. Helin) antibodies and 4,6-diamidino-2-phenylindole
(DAPI) (Sigma).
For in situ hybridization analysis, embryoswere processed with digoxigenin-
labeled Nkx2.5, Tbx5, MLC2v (gifts from J. Martin), ANF (gift from B. Bruneau),
UTX and UTY riboprobes, as described previously (Wilkinson andNieto, 1993).
cDNA for mouse UTX and UTY were cloned to pBluescript vector to generate
riboprobes.
For H&E staining, transverse sections of E9 embryos were stained with
hematoxylin and eosin according to standard techniques.
RNA Extraction and Quantitative RT-PCR
Total RNAs were extracted using the Trizol (Invitrogen) and reverse-tran-
scribed using the SuperScript III First-Strand Synthesis System (Invitrogen).
The levels of mRNA were determined using quantitative RT-PCR (Mx3000P,
Stratagene). The levels of mRNA were normalized against the levels of cyclo-
philin A. The primers used were as follows: ANF, forward 50-GAAAAGGCAG
TCGATTCTGC-30, reverse 50-CAGAGTGGGAGAGGCAAGAC-30; MLC2v,
forward 50-ACAGAGACGGCTTCATCGAC-30, reverse 50-TGAATGCGTTGA
GAATGGTC-30; Myh6, forward 50-CACTCAATGAGACGGTGGTG-30, reverse
50-GTGGGTGGTCTTCAGGTTTG-30; SRF, forward 50-CCTTCAGCAAGAGG
AAGACG-30, reverse 50-GAGAGTCTGGCGAGTTGAGG-30; Nkx2.5, forward
50-CTTGAACACCGTGCAGAGTC-30, reverse 50-GGTGGGTGTGAAATCTGAG
G-30; UTX, forward 50-CTGAAGGGAAAGTGGAGTCTG-30, reverse 50-TCGAC
ATAAAGCACCTCCTG-30; UTY, forward 50- ATAGTGTCCAGACAGCTTCA-30,
reverse 50-GAGGTAGGAATACGTAAGAA-30; Tbx5, forward 50- GTGGCTGAA
GTTCCACGAAG-30, reverse 50-GGCTCTGCTTTGCCAGTTAC-30; a-CA,
forward 50-TGCTTCTGGAAGAACCACAG-30, reverse 50-TCACGGACAATTTC
ACGTTC-30; GATA4, forward 50-CCCCTCATTAAGCCTCAGC-30, reverse
50-ATTCAGGTTCTTGGGCTTCC-30; cyclophilin A, forward 50-GTCTCCTTCG
AGCTGTTTGC-30, reverse 50-GATGCCAGGACCTGTATGCT-30.
Whole-Mount X-Gal Staining
Embryos were harvested, fixed in 4%paraformaldehyde for 10min at 4C, and
washed in rinse solution (100mM sodium phosphate, pH7.5, 2mMMgCl2, and
0.02%NP-40) three times for 20 min each at 4C. Then, embryos were stained
with X-gal staining solution (1 mg/ml X-gal, 5 mM potassium ferricyanide and
5 mM potassium ferrocyanide in rinse solution) at 37C overnight. Embryos
were postfixed in 4% paraformaldehyde for 1 hr at room temperature and
washed in rinse buffer. To make the embryos transparent, embryos were incu-
bated in serial dilution of glycerol (25%, 50%, 80% in PBS) for at least 5 hr in
each step.
DNA Constructs
ANF:Luc, Flag-Nkx2.5, Flag-GATA4, HA-Tbx5 (gifts from B. Bruneau), Myc-
UTX (a gift from K. Gei), shRNA-human UTX (a gift from K. Helin), SM22:Luc
(a gift from J. Epstein), aCA:Luc (a gift from M. Parmacek), SRE:luc, andc.
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2001; Chen et al., 2002; Hong et al., 2007; Lee et al., 2000). Mouse Pax6 full-
length was cloned to pcDNA3HA vector. shRNA-mouse UTX target sequence
is AAGTTAGCAGTGGAACGTTAT.Luciferase Reporter Assays
HEK293T cells were cultured in DMEM media supplemented with 10% fetal
bovine serum. Cells were plated in 48-well plate and incubated for 24 hr,
and transient transfections were performed using Superfect (QIAGEN). An
actin-b-galactosidase plasmid was cotransfected for normalization of trans-
fection efficiency, and empty vectors were used to equalize the total
amount of DNA. Cells were harvested 48 hr after transfection. Cell extracts
were assayed for luciferase activity and the values were normalized with
b-galactosidase activity. All transfections were repeated independently at
least three times. Data are represented as the mean of triplicate values ob-
tained from representative experiments. Error bars represent standard
deviation.CoIP and Western Blotting Assays
HEK293T cells were seeded on 10 cm tissue cultures dishes and expression
vectors were transfected as described above. Forty eight hours later, cells
were harvested and lysed in IP buffer (20 mM Tris-HCl, pH 8.0, 0.5% NP-40,
1 mM EDTA, 150 mM NaCl, 2 mM PMSF, 10% glycerol, 4 mM Na3VO4,
200 mM NaF, 20 mM Na-pyroPO4, and protease inhibitor cocktail). In these
studies, precipitations were performed with a-Myc (Abcam), a-HA (Covance)
and a-Brg1 (Millipore) antibodies. The interactions were monitored by western
blotting assays using a-Flag (Sigma), a-Myc (Abcam), a-Brg1 (Millipore), and
a-UTX (a gift from K. Helin) antibodies.
E12.5 mouse embryonic heart tissues were lysed in IP buffer, immunopre-
cipitated with a-UTX (a gift from K. Helin), a-SRF (G-20), a-Tbx5 (H-70),
a-Nkx2.5 (H-114), and a-Gata4 (H-112) antibodies from Santa Cruz, and
then the presence of UTX in immunopurified complex wasmonitored by immu-
noblotting with a-UTX antibody.
Western blotting assays with a-cleaved Caspase3 (Asp175) (Cell Signaling)
antibody was used to monitor apoptotic cells in ESCs and cEBs. a-Oct34
(N-19, Santa Cruz) antibodywas used tomonitor the self-renewal and differen-
tiation of ESCs. a-tubulin (Santa Cruz) antibody was used as loading control.ChIP Assays
P19 cells were transfectedwith shRNA against mouse UTX, knockdown insen-
sitive form of human UTX wild-type or catalytically inactive UTX mutant
UTX-H1146A using Lipofectamine2000 (Invitrogen). Forty eight hours later,
cells were washed with PBS and growth media (minimum essential medium
a, 7.5% bovine calf serum and 2.5% fetal bovine serum) was replaced with
MEMa supplemented with 0.5% fetal bovine serum and incubated for 17 hr.
Serum shock was applied by changing the low serum to 20% fetal bovine
serum for 2 hr. E12.5 mouse embryonic heart, limbs, and brain were used
for ChIP experiments. ChIP experiments were performed as previously
described (Lee and Pfaff, 2003). Briefly, cells were crosslinked with formalde-
hyde and sonicated. Protein-DNA complexes were precipitated with a-UTX (a
gift from K. Helin), a-Brg1 (Millipore), a-H3K27me3 and a-H3K4me3 (Millipore)
antibodies. The purified DNA was amplified using PCR and the SYBR green kit
(Invitrogen) for quantitation. Quantitative results were normalized to the total
input control. Primers used were ANF-enhancer, forward 50-TGAATCAGGTG
TGAAGCTAGCTCC-30, reverse 50-GGAGCAGAAAAGAGTCCTTGGTTA-30;
ANF-exon1, forward 50-GGGAGATGCTGGCAGCTAGGAGAC-30, reverse
50-CTTGAAATCCATCAGATCTGTGTT-30; Baf60c-enhancer, forward 50-TTA
AGCAGTCAGAAGATCTCCTTG-30, reverse 50-GGCTCTCCACCTCAATAGG
TTCCT-30. All experiments were repeated independently at least three times.
Data are represented as the mean of triplicate values obtained from represen-
tative experiments. Error bars represent standard deviation.SUPPLEMENTAL INFORMATION
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